Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center.

Autor: Tverdek FP; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aitken SL; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth McGovern Medical School, Houston, Texas, USA., Mulanovich VE; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Adachi J; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wu C; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cantu SS; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McDaneld PM; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chemaly RF; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Apr 25; Vol. 11 (5), pp. ofae235. Date of Electronic Publication: 2024 Apr 25 (Print Publication: 2024).

Structural insights into the molecular mechanism of high-level ceftazidime-avibactam resistance conferred by CMY-185.

Autor: Kawai A; Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.; Center for Infectious Disease Research, Fujita Health University, Toyoake, Aichi, Japan., Shropshire WC; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Suzuki M; Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.; Center for Infectious Disease Research, Fujita Health University, Toyoake, Aichi, Japan., Borjan J; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aitken SL; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bachman WC; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., McElheny CL; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Bhatti MM; Division of Pathology/Lab Medicine, Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Shields RK; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA., Shelburne SA; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Doi Y; Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.; Center for Infectious Disease Research, Fujita Health University, Toyoake, Aichi, Japan.; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Publikováno v: MBio [mBio] 2024 Feb 14; Vol. 15 (2), pp. e0287423. Date of Electronic Publication: 2024 Jan 05.

Prophylaxis Against Pneumocystis Pneumonia-Reply.

Autor: Zhou S; Department of Internal Medicine, Michigan Medicine, Ann Arbor., Aitken SL; Department of Pharmacy, Michigan Medicine, Ann Arbor.

Publikováno v: JAMA [JAMA] 2023 Nov 21; Vol. 330 (19), pp. 1909.

High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant.

Autor: Shropshire WC; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Endres BT; Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA.; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borjan J; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Aitken SL; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bachman WC; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., McElheny CL; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Wu CT; Program in Diagnostic Genetics and Genomics, MD Anderson Cancer Center School of Health Professions, Houston, TX, USA., Egge SL; Department of Internal Medicine, Division of Infectious Diseases, Houston Methodist Hospital, Houston, TX, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX, USA., Khan A; Department of Microbiology and Molecular Genetics, University of Texas Health Science Center, McGovern School of Medicine, Houston, TX, USA., Miller WR; Department of Internal Medicine, Division of Infectious Diseases, Houston Methodist Hospital, Houston, TX, USA.; Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX, USA., Bhatti MM; Department of Laboratory Medicine, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Saharasbhojane P; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kawai A; Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Shields RK; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Shelburne SA; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Doi Y; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Microbiology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.; Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2023 Oct 03; Vol. 78 (10), pp. 2442-2450.

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.

Autor: Tamma PD; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Aitken SL; Department of Pharmacy, University of Michigan Health, Ann Arbor, Michigan, USA., Bonomo RA; Medical Service and Center for Antimicrobial Resistance and Epidemiology, Louis Stokes Cleveland Veterans Affairs Medical Center, University Hospitals Cleveland Medical Center and Departments of Medicine, Pharmacology, Molecular Biology, and Microbiology, Case Western Reserve University, Cleveland, Ohio, USA., Mathers AJ; Departments of Medicine and Pathology, University of Virginia, Charlottesville, Virginia, USA., van Duin D; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Clancy CJ; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Jul 18. Date of Electronic Publication: 2023 Jul 18.